Insider Activity of Chambers Michael Andrew
According to the SEC Form 4 filings, Chambers Michael Andrew, being in a position of
- director at Sarepta Therapeutics, Inc.,оver the last 12 months, has bought 37038 shares for $4.96M, and sold 0 shares,over all time since 2022-08-19, has bought 145680 shares for $16.65M, and sold 0 shares.
The largest purchase of all time was on 2024-08-16 and amounted to 37038 shares of Sarepta Therapeutics, Inc. for $4.96M.
Biography of Chambers Michael Andrew
No biography is available at this moment.